 Trevor Nydam
Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 36 | 2023 | 695 | 7.880 |
Why?
| | Gastric Bypass | 4 | 2023 | 91 | 2.630 |
Why?
| | Tissue and Organ Procurement | 6 | 2022 | 226 | 2.470 |
Why?
| | Obesity, Morbid | 4 | 2023 | 197 | 2.340 |
Why?
| | Thrombelastography | 12 | 2023 | 129 | 2.260 |
Why?
| | Kidney Transplantation | 11 | 2022 | 538 | 2.250 |
Why?
| | Living Donors | 8 | 2022 | 270 | 2.040 |
Why?
| | Tissue Plasminogen Activator | 7 | 2023 | 204 | 1.990 |
Why?
| | Tissue Donors | 7 | 2022 | 314 | 1.720 |
Why?
| | Blood Coagulation Disorders | 4 | 2022 | 154 | 1.660 |
Why?
| | Death | 4 | 2023 | 106 | 1.650 |
Why?
| | Bariatric Surgery | 2 | 2023 | 160 | 1.320 |
Why?
| | Fibrinolysis | 5 | 2023 | 126 | 1.280 |
Why?
| | Donor Selection | 5 | 2021 | 65 | 1.230 |
Why?
| | Carcinoma, Hepatocellular | 8 | 2023 | 210 | 1.230 |
Why?
| | Liver Neoplasms | 8 | 2023 | 504 | 1.050 |
Why?
| | Cold Ischemia | 4 | 2021 | 27 | 1.000 |
Why?
| | Kidney | 8 | 2022 | 1182 | 0.950 |
Why?
| | Graft Survival | 10 | 2023 | 443 | 0.940 |
Why?
| | Delayed Graft Function | 3 | 2022 | 26 | 0.850 |
Why?
| | Hepatitis C | 3 | 2022 | 218 | 0.830 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 29 | 0.820 |
Why?
| | Blood Transfusion | 4 | 2019 | 265 | 0.760 |
Why?
| | End Stage Liver Disease | 5 | 2021 | 61 | 0.740 |
Why?
| | Kidney Failure, Chronic | 3 | 2023 | 489 | 0.720 |
Why?
| | Organ Preservation | 2 | 2018 | 64 | 0.710 |
Why?
| | Reperfusion | 1 | 2020 | 35 | 0.710 |
Why?
| | Gastrectomy | 4 | 2023 | 81 | 0.690 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 37 | 0.690 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 63 | 0.680 |
Why?
| | Hepatitis C, Chronic | 1 | 2022 | 150 | 0.670 |
Why?
| | Heart Failure | 2 | 2023 | 1958 | 0.650 |
Why?
| | Graft Rejection | 2 | 2020 | 511 | 0.650 |
Why?
| | Postoperative Complications | 3 | 2020 | 2122 | 0.630 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 23 | 0.620 |
Why?
| | Apoptosis | 5 | 2021 | 2349 | 0.620 |
Why?
| | Humans | 64 | 2023 | 114043 | 0.620 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 37 | 0.610 |
Why?
| | Blood Coagulation | 6 | 2023 | 200 | 0.610 |
Why?
| | Caspase Inhibitors | 1 | 2018 | 77 | 0.600 |
Why?
| | Resuscitation | 1 | 2020 | 221 | 0.600 |
Why?
| | Liver | 7 | 2022 | 1633 | 0.600 |
Why?
| | Thrombophilia | 1 | 2018 | 61 | 0.590 |
Why?
| | Pneumoperitoneum | 1 | 2017 | 11 | 0.580 |
Why?
| | Klebsiella Infections | 1 | 2017 | 23 | 0.580 |
Why?
| | Cholecystitis | 1 | 2017 | 17 | 0.580 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2018 | 70 | 0.580 |
Why?
| | Heart Transplantation | 1 | 2023 | 670 | 0.580 |
Why?
| | Cholecystectomy | 1 | 2017 | 45 | 0.580 |
Why?
| | Quinolines | 1 | 2018 | 129 | 0.570 |
Why?
| | Organ Transplantation | 1 | 2019 | 159 | 0.540 |
Why?
| | Retrospective Studies | 19 | 2023 | 12521 | 0.510 |
Why?
| | Parents | 2 | 2020 | 1181 | 0.500 |
Why?
| | Middle Aged | 23 | 2022 | 26605 | 0.480 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2023 | 850 | 0.440 |
Why?
| | Acute Kidney Injury | 4 | 2021 | 637 | 0.430 |
Why?
| | Wounds and Injuries | 4 | 2019 | 674 | 0.410 |
Why?
| | Registries | 1 | 2020 | 1764 | 0.410 |
Why?
| | Creatinine | 4 | 2023 | 424 | 0.400 |
Why?
| | Decision Support Techniques | 4 | 2020 | 336 | 0.390 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2014 | 1128 | 0.380 |
Why?
| | Saline Solution, Hypertonic | 3 | 2014 | 39 | 0.380 |
Why?
| | Male | 32 | 2023 | 55396 | 0.360 |
Why?
| | Multiple Organ Failure | 1 | 2011 | 116 | 0.350 |
Why?
| | NF-kappa B | 4 | 2014 | 636 | 0.340 |
Why?
| | Brain Death | 2 | 2022 | 30 | 0.340 |
Why?
| | Transplant Recipients | 2 | 2022 | 136 | 0.330 |
Why?
| | Ablation Techniques | 2 | 2020 | 25 | 0.320 |
Why?
| | Thrombocytopenia | 1 | 2011 | 177 | 0.320 |
Why?
| | Thrombosis | 3 | 2022 | 295 | 0.320 |
Why?
| | Warm Ischemia | 2 | 2020 | 11 | 0.320 |
Why?
| | Waiting Lists | 5 | 2022 | 206 | 0.310 |
Why?
| | Female | 25 | 2023 | 59325 | 0.310 |
Why?
| | Treatment Outcome | 12 | 2023 | 9049 | 0.290 |
Why?
| | Pancreatic Neoplasms | 3 | 2019 | 721 | 0.290 |
Why?
| | Adult | 16 | 2022 | 30375 | 0.270 |
Why?
| | Risk Factors | 11 | 2023 | 8614 | 0.270 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1791 | 0.270 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 244 | 0.270 |
Why?
| | Necrosis | 3 | 2021 | 209 | 0.260 |
Why?
| | Epithelial Cells | 3 | 2014 | 946 | 0.260 |
Why?
| | Time Factors | 10 | 2021 | 6077 | 0.260 |
Why?
| | Metabolomics | 3 | 2019 | 511 | 0.260 |
Why?
| | United States | 10 | 2022 | 12137 | 0.250 |
Why?
| | Prospective Studies | 4 | 2020 | 6195 | 0.250 |
Why?
| | Obesity | 3 | 2023 | 2505 | 0.250 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 334 | 0.240 |
Why?
| | Coronavirus Infections | 2 | 2020 | 326 | 0.240 |
Why?
| | Colonoscopy | 1 | 2007 | 197 | 0.240 |
Why?
| | Tumor Burden | 3 | 2020 | 258 | 0.230 |
Why?
| | Lung | 3 | 2014 | 3521 | 0.230 |
Why?
| | Risk Assessment | 7 | 2022 | 2958 | 0.210 |
Why?
| | Antiviral Agents | 2 | 2022 | 642 | 0.210 |
Why?
| | Choledochostomy | 1 | 2022 | 11 | 0.210 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2022 | 25 | 0.210 |
Why?
| | Plasminogen Activator Inhibitor 1 | 2 | 2022 | 75 | 0.210 |
Why?
| | Caspase 1 | 2 | 2021 | 140 | 0.210 |
Why?
| | Adenocarcinoma | 2 | 2019 | 787 | 0.200 |
Why?
| | Allografts | 1 | 2023 | 121 | 0.200 |
Why?
| | Bile Ducts | 1 | 2022 | 68 | 0.200 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.200 |
Why?
| | Survival Rate | 3 | 2021 | 1638 | 0.200 |
Why?
| | Preoperative Period | 2 | 2019 | 102 | 0.190 |
Why?
| | Hemostatics | 1 | 2022 | 44 | 0.190 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 224 | 0.190 |
Why?
| | Nephrectomy | 2 | 2020 | 149 | 0.180 |
Why?
| | Reperfusion Injury | 2 | 2021 | 252 | 0.180 |
Why?
| | Aged | 10 | 2021 | 18969 | 0.180 |
Why?
| | Cell Line | 3 | 2018 | 2629 | 0.180 |
Why?
| | Intraoperative Period | 1 | 2020 | 51 | 0.180 |
Why?
| | Shock, Hemorrhagic | 2 | 2016 | 152 | 0.180 |
Why?
| | Computer Systems | 1 | 2020 | 46 | 0.180 |
Why?
| | Viscosity | 1 | 2020 | 81 | 0.170 |
Why?
| | Models, Animal | 2 | 2020 | 340 | 0.170 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 19 | 0.170 |
Why?
| | Liver Function Tests | 1 | 2020 | 103 | 0.170 |
Why?
| | Blood Coagulation Tests | 1 | 2020 | 51 | 0.170 |
Why?
| | Caspase 3 | 2 | 2018 | 234 | 0.170 |
Why?
| | Hepacivirus | 1 | 2022 | 228 | 0.170 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4680 | 0.170 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 246 | 0.170 |
Why?
| | Liver Diseases | 1 | 2022 | 254 | 0.160 |
Why?
| | Thromboembolism | 1 | 2020 | 92 | 0.160 |
Why?
| | Salvage Therapy | 1 | 2020 | 127 | 0.160 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 91 | 0.160 |
Why?
| | Critical Care | 1 | 2023 | 472 | 0.160 |
Why?
| | Follow-Up Studies | 4 | 2020 | 4392 | 0.160 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 285 | 0.160 |
Why?
| | Transplantation, Homologous | 1 | 2020 | 377 | 0.160 |
Why?
| | Klebsiella pneumoniae | 1 | 2017 | 41 | 0.140 |
Why?
| | Plasma | 2 | 2016 | 181 | 0.140 |
Why?
| | Hepatectomy | 1 | 2018 | 118 | 0.140 |
Why?
| | Platelet Count | 2 | 2022 | 79 | 0.140 |
Why?
| | Drug Overdose | 1 | 2021 | 292 | 0.140 |
Why?
| | Goals | 1 | 2018 | 145 | 0.140 |
Why?
| | Pancreatectomy | 1 | 2018 | 167 | 0.130 |
Why?
| | Early Detection of Cancer | 1 | 2019 | 305 | 0.130 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 260 | 0.130 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.130 |
Why?
| | Aortic Valve Insufficiency | 1 | 2015 | 46 | 0.130 |
Why?
| | Airway Extubation | 1 | 2016 | 43 | 0.120 |
Why?
| | ABO Blood-Group System | 1 | 2015 | 29 | 0.120 |
Why?
| | Weight Loss | 1 | 2020 | 642 | 0.120 |
Why?
| | Renal Artery | 1 | 2015 | 26 | 0.120 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 39 | 0.120 |
Why?
| | Isoantibodies | 1 | 2015 | 52 | 0.120 |
Why?
| | Microsurgery | 1 | 2015 | 58 | 0.120 |
Why?
| | Rewarming | 1 | 2014 | 16 | 0.120 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 127 | 0.120 |
Why?
| | Case-Control Studies | 2 | 2019 | 3003 | 0.120 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 413 | 0.120 |
Why?
| | Phosphorylation | 4 | 2014 | 1558 | 0.110 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 284 | 0.110 |
Why?
| | Biomarkers | 3 | 2019 | 3397 | 0.110 |
Why?
| | Health Services Accessibility | 1 | 2020 | 756 | 0.110 |
Why?
| | Incidence | 1 | 2020 | 2314 | 0.110 |
Why?
| | Kidney Tubules | 1 | 2014 | 107 | 0.110 |
Why?
| | Young Adult | 5 | 2021 | 10444 | 0.110 |
Why?
| | Age Factors | 4 | 2021 | 2885 | 0.110 |
Why?
| | Erythrocyte Transfusion | 2 | 2016 | 161 | 0.110 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2015 | 152 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1032 | 0.110 |
Why?
| | Metabolome | 1 | 2016 | 274 | 0.110 |
Why?
| | Cholestasis | 1 | 2016 | 225 | 0.110 |
Why?
| | Osmolar Concentration | 1 | 2013 | 169 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3498 | 0.100 |
Why?
| | Animals | 9 | 2021 | 31565 | 0.100 |
Why?
| | Recovery of Function | 1 | 2016 | 573 | 0.100 |
Why?
| | Microvessels | 1 | 2013 | 66 | 0.100 |
Why?
| | Sirolimus | 1 | 2013 | 181 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2014 | 368 | 0.100 |
Why?
| | Autophagy | 1 | 2014 | 235 | 0.100 |
Why?
| | Aortic Valve Stenosis | 1 | 2015 | 269 | 0.100 |
Why?
| | Patient Selection | 1 | 2015 | 629 | 0.100 |
Why?
| | Models, Biological | 1 | 2019 | 1611 | 0.100 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 227 | 0.100 |
Why?
| | Hypoxia | 1 | 2016 | 956 | 0.080 |
Why?
| | Markov Chains | 2 | 2020 | 114 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2013 | 641 | 0.080 |
Why?
| | Mice | 6 | 2021 | 14841 | 0.080 |
Why?
| | Postoperative Period | 2 | 2020 | 288 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1310 | 0.080 |
Why?
| | Injury Severity Score | 1 | 2011 | 472 | 0.080 |
Why?
| | Neoadjuvant Therapy | 2 | 2020 | 305 | 0.080 |
Why?
| | Odds Ratio | 1 | 2011 | 951 | 0.080 |
Why?
| | Renal Dialysis | 2 | 2023 | 375 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2020 | 140 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 391 | 0.070 |
Why?
| | Colonoscopes | 1 | 2007 | 5 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 393 | 0.070 |
Why?
| | Barium Sulfate | 1 | 2007 | 15 | 0.070 |
Why?
| | Mesentery | 1 | 2007 | 41 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2007 | 50 | 0.070 |
Why?
| | Quality of Life | 1 | 2018 | 2343 | 0.070 |
Why?
| | Cecum | 1 | 2007 | 32 | 0.070 |
Why?
| | Cause of Death | 2 | 2021 | 362 | 0.070 |
Why?
| | Enema | 1 | 2007 | 37 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 247 | 0.070 |
Why?
| | Paraneoplastic Syndromes | 1 | 2007 | 12 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2007 | 63 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2009 | 489 | 0.070 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2007 | 43 | 0.070 |
Why?
| | Blotting, Western | 1 | 2009 | 1143 | 0.070 |
Why?
| | Child | 6 | 2022 | 18400 | 0.070 |
Why?
| | Recurrence | 2 | 2023 | 925 | 0.070 |
Why?
| | Inflammation Mediators | 1 | 2009 | 475 | 0.070 |
Why?
| | Cell Survival | 1 | 2009 | 1014 | 0.060 |
Why?
| | Logistic Models | 1 | 2011 | 1829 | 0.060 |
Why?
| | Survival Analysis | 2 | 2020 | 1206 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1075 | 0.060 |
Why?
| | Databases, Factual | 2 | 2021 | 1125 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2020 | 6306 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2019 | 622 | 0.060 |
Why?
| | Erythrocytes | 1 | 2009 | 568 | 0.060 |
Why?
| | Inflammation | 1 | 2014 | 2464 | 0.060 |
Why?
| | Trauma Centers | 1 | 2006 | 347 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1078 | 0.050 |
Why?
| | Perioperative Period | 1 | 2022 | 47 | 0.050 |
Why?
| | Platelet Transfusion | 1 | 2022 | 55 | 0.050 |
Why?
| | Pandemics | 2 | 2020 | 1310 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2020 | 1162 | 0.050 |
Why?
| | Hemostasis | 1 | 2022 | 64 | 0.050 |
Why?
| | Patients | 1 | 2023 | 163 | 0.050 |
Why?
| | Child Abuse | 1 | 2006 | 456 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1824 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2537 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2272 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2007 | 592 | 0.040 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2020 | 8 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 73 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 5038 | 0.040 |
Why?
| | Partial Thromboplastin Time | 1 | 2020 | 50 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2020 | 182 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 326 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 79 | 0.040 |
Why?
| | Blood Viscosity | 1 | 2019 | 14 | 0.040 |
Why?
| | Databases as Topic | 1 | 1999 | 63 | 0.040 |
Why?
| | alpha-Fetoproteins | 1 | 2019 | 31 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 618 | 0.040 |
Why?
| | Long-Term Care | 1 | 1999 | 77 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 268 | 0.040 |
Why?
| | Ischemia | 1 | 2020 | 361 | 0.040 |
Why?
| | Lymphatic Metastasis | 1 | 2018 | 275 | 0.040 |
Why?
| | Sepsis | 1 | 2022 | 507 | 0.030 |
Why?
| | Mutation | 1 | 2007 | 3338 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 36 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 69 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2020 | 614 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 319 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 4501 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 1999 | 561 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 17800 | 0.030 |
Why?
| | Endothelial Cells | 2 | 2013 | 677 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 556 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 53 | 0.030 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 29 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2562 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 126 | 0.030 |
Why?
| | Transplants | 1 | 2015 | 36 | 0.030 |
Why?
| | Critical Illness | 1 | 2020 | 640 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 135 | 0.030 |
Why?
| | Shock | 1 | 2016 | 83 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 452 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1117 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 465 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 80 | 0.030 |
Why?
| | Femoral Artery | 1 | 2015 | 165 | 0.030 |
Why?
| | Macrolides | 1 | 2014 | 57 | 0.030 |
Why?
| | Motivation | 1 | 2018 | 488 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 308 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 3861 | 0.030 |
Why?
| | Reoperation | 1 | 2016 | 513 | 0.030 |
Why?
| | Hepatocytes | 1 | 2014 | 195 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2371 | 0.030 |
Why?
| | Leukocytes | 1 | 2014 | 272 | 0.030 |
Why?
| | Infant | 2 | 2021 | 7943 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2013 | 147 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 9114 | 0.030 |
Why?
| | Swine | 1 | 2014 | 687 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 249 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2013 | 229 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1422 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3315 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2013 | 426 | 0.020 |
Why?
| | Cell Communication | 1 | 2013 | 277 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1015 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2013 | 268 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2009 | 35 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 55 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2009 | 115 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1381 | 0.020 |
Why?
| | Veterans | 1 | 1999 | 1248 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2764 | 0.020 |
Why?
| | Neutrophils | 1 | 2013 | 1089 | 0.020 |
Why?
| | Laparotomy | 1 | 2007 | 101 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 802 | 0.020 |
Why?
| | Blood Preservation | 1 | 2009 | 231 | 0.020 |
Why?
| | Intestine, Small | 1 | 2007 | 121 | 0.020 |
Why?
| | Exons | 1 | 2007 | 301 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 813 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2009 | 1036 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2007 | 552 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2182 | 0.010 |
Why?
| | Hypoglycemia | 1 | 2007 | 386 | 0.010 |
Why?
| | Glucose | 1 | 2007 | 899 | 0.010 |
Why?
| | Manuals as Topic | 1 | 1999 | 13 | 0.010 |
Why?
| | Rats | 1 | 2007 | 4913 | 0.010 |
Why?
| | Demography | 1 | 1999 | 258 | 0.010 |
Why?
| | Health Resources | 1 | 1999 | 120 | 0.010 |
Why?
| | Nursing Homes | 1 | 1999 | 138 | 0.010 |
Why?
| | Patient Admission | 1 | 1999 | 175 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 1999 | 240 | 0.010 |
Why?
| | Colorado | 1 | 2006 | 4090 | 0.010 |
Why?
| | Women's Health | 1 | 1999 | 270 | 0.010 |
Why?
| | Data Collection | 1 | 1999 | 618 | 0.010 |
Why?
| | Ambulatory Care | 1 | 1999 | 479 | 0.010 |
Why?
| | Internet | 1 | 1999 | 591 | 0.010 |
Why?
| | Sex Factors | 1 | 1999 | 1706 | 0.010 |
Why?
| | Hospitalization | 1 | 1999 | 1762 | 0.010 |
Why?
|
|
Nydam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|